Century Therapeutics (IPSC) Earnings Date & Reports
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IPSC is expected to report earnings to fall 143.49% to -38 cents per share on August 07
Q2'25
Est.
$-0.39
Q1'25
Beat
by $0.96
Q4'24
Est.
$-0.41
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.07
The last earnings report on May 16 showed earnings per share of 88 cents, beating the estimate of -7 cents. With 2.28M shares outstanding, the current market capitalization sits at 48.51M.